Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

FDA Releases Guidance on Clinical Trial Conduct During COVID-19 Pandemic

Alert

  • News and Insights
  • FDA Releases Guidance on Clinical Trial Conduct During COVID-19 Pandemic

The U.S. Food and Drug Administration (FDA) released guidance on March 18, 2020 entitled “FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic” (Guidance).1 The Guidance comes at a critical time, as clinical trial sponsors, investigators, and Institutional Review Boards (IRBs) grapple with the measures needed to ensure the safety of clinical trial participants while maintaining good clinical practice (GCP) and preserving clinical trial integrity during this unprecedented public health emergency. FDA is implementing the recommendations in the Guidance immediately, but comments may still be submitted to the Agency for consideration.

View More

Share links:

Share links:

Related Professionals

Related Practices

Related Industries

Related Offices

Related Regions

Related News & Insights